• Nachrichtendetail
• 

27.02.2024 13:04:30 - dpa-AFX: *LIGAND PHARMA Q4 CORE ADJ. NET INCOME RISES TO $18.6 MLN OR $1.05/SHR FROM $13.0 MLN OR $0.75/SHR LAST YEAR

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	77,500	08.07.24 09:06:37	+1,500	+1,97%	79,000	80,500	77,500	76,000